Literature DB >> 26880382

The PD-1/PD-L1 axis in the pathogenesis of urothelial bladder cancer and evaluating its potential as a therapeutic target.

Antonio D Bardoli1, Mehran Afshar2, Richard Viney3, Mike Foster4, Emilio Porfiri3, Anjali Zarkar3, Robert Stevenson3, Nicholas D James2, Richard T Bryan5, Prashant Patel5,3.   

Abstract

Entities:  

Keywords:  B7-H1; PD-1; PD-L1; bladder cancer; outcome; pathogenesis; target; urothelial carcinoma

Mesh：

Substances：

Year:  2016        PMID： 26880382     DOI： 10.2217/fon.15.337

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  4 in total

1.  Expression and prognostic value of PD-L1 in non-schistosoma-associated urinary bladder squamous cell carcinoma.

Authors:  Zhenhua Liu; Yisen Meng; Yudong Cao; Yuke Chen; Yu Fan; Shaobo Li; Qun He; Shiliang Wu; Wei Yu; Jie Jin
Journal:  Transl Androl Urol       Date:  2020-04

Review 2.  Small-Molecule Targets in Tumor Immunotherapy.

Authors:  Hui-Fang Zhu; Yan Li
Journal:  Nat Prod Bioprospect       Date:  2018-07-05

3.  Expression of B7 Homolog 1 (B7H1) Is Associated with Clinicopathologic Features in Urothelial Bladder Cancer.

Authors:  Qingyuan Li; Feng Li; Jizhong Che; Yang Zhao; Chengjian Qiao
Journal:  Med Sci Monit       Date:  2018-10-13

4.  Combined inhibition of JAK1,2/Stat3‑PD‑L1 signaling pathway suppresses the immune escape of castration‑resistant prostate cancer to NK cells in hypoxia.

Authors:  Li-Jun Xu; Qi Ma; Jin Zhu; Jian Li; Bo-Xin Xue; Jie Gao; Chuan-Yang Sun; Ya-Chen Zang; Yi-Bin Zhou; Dong-Rong Yang; Yu-Xi Shan
Journal:  Mol Med Rep       Date:  2018-04-20       Impact factor: 2.952
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.